Jason M. Jennings

Jason M. Jennings

Auto-generated profile, based on publicly available information

Jason M. Jennings

Colorado Joint Replacement, Denver, Colorado; Department of Mechanical and Materials Engineering, University of Denver, Denver, Colorado

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2018 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JFJason R. Falvey
Jason R. Falvey
MBMichael J. Bade
Michael J. Bade
JFJeri E. Forster
Jeri E. Forster
RBRobert E. Burke
Robert E. Burke
JJJason M. Jennings
Jason M. Jennings
JSJennifer E. Stevens-Lapsley
Jennifer E. Stevens-Lapsley
Background: Home-health-care utilization after total knee arthroplasty (TKA) is increasing. Recent publications have suggested that supervised rehabilitation is not needed to optimize functional recovery after TKA; however, few studies have evaluated patients in home-health-care settings. The objectives of this study were to (1) determine whether physical therapy (PT) utilization is associated with functional improvements for patients in home-health-care settings after TKA and (2) determine which factors are related to utilization of PT. Methods: This study was an analysis of Medicare home-health-care claims data for patients treated with a TKA in 2012 who received home-health-care services for postoperative rehabilitation. Multivariable linear regression models were used to evaluate relationships between PT utilization and recovery in activities of daily living (ADLs). Negative binomial regression models were used to determine factors associated with PT utilization. Results: Records from 5,967 Medicare beneficiaries were evaluated. Low home-health-care PT utilization (≤5 visits) was associated with less improvement in ADLs compared with 6 to 9 visits, 10 to 13 visits, or ≥14 visits. Compared with low home-health-care utilization, utilization of 6 to 9 visits was associated with a 25% greater improvement in ADLs over the home-health-care episode (p < 0.0001); 10 to 13 visits, with a 40% greater improvement (p < 0.0001); and ≥14 visits, with a 50% greater improvement (p < 0.0001). The findings remained robust following adjustments for medical complexity, baseline functional status, and home-health-care episode duration. After adjustment, lower PT utilization was observed for patients receiving home health care from rural agencies (10.7% fewer visits, 95% confidence interval [CI] = 7.9% to 13.7%), those with depressive symptoms (4.8% fewer visits, 95% CI = 1.3% to 8.3%), and those with any baseline dyspnea (5.3% fewer visits, 95% CI = 3.1% to 7.5%). Conclusions: Low home-health-care PT utilization was significantly associated with worse recovery in ADLs after TKA for Medicare beneficiaries, after controlling for medical complexity, baseline function, and home-health-care episode duration. Patients who are served by rural agencies or who have higher medical complexity receive fewer PT visits after TKA and may need closer monitoring to ensure optimal functional recovery. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

18 May 2018 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Open access
JJJason M. Jennings
Jason M. Jennings
MWMichael A. Williams
Michael A. Williams
DLDaniel L. Bs Levy
Daniel L. Bs Levy
RJRoseann M. Ba Johnson
Roseann M. Ba Johnson
CECatherine L. Bs Eschen
Catherine L. Bs Eschen
DDDouglas A. Dennis
Douglas A. Dennis
Background: Marijuana use has become more accessible since its recent legalization in several states. However, its use in a total joint arthroplasty population to our knowledge has not been reported, and the implications of its use in this setting remain unclear. Questions/purposes: We report (1) the self-reported use of marijuana in patients undergoing total joint arthroplasty both before and after its legalization; and (2) clinical and demographic factors associated with marijuana use in patients undergoing total joint arthroplasty. Methods: One thousand records of patients undergoing primary total joint arthroplasty (500 consecutive before and 500 consecutive after the legalization of the commercial sale of marijuana in Colorado) were included for analysis. Preoperative medical history and physicals were retrospectively reviewed for self-reported and reasons (medicinal versus recreational) for use. Additionally, patient records were used to determine insurance type, age, gender, smoking status, history of substance abuse, preoperative narcotic use, alcohol intake, and the type of arthroplasty performed. Results: Self-reported use after legalization dramatically increased from 1% (four of 500) to 11% (55 of 500) (odds ratio [OR], 15.3 [95% confidence interval, 5.5–42.6]; p < 0.001) after legalization. For those reporting use after legalization, 46% (25 of 55) of patients reported recreational use, 26% (14 of 55) medicinal use, 27% (15 of 55) did not report a reason for use, and 2% (one of 55) reported both recreational and medicinal use. Factors associated with use included younger age (with a 10-year mean difference between the groups [p < 0.001]), male gender (36 of 59 users [61%] versus 411 of 941 nonusers [44%]; OR, 2.02; p < 0.01), current smokers (22 of 59 users [37%] versus 54 of 941 [6%] nonusers; OR, 0.09; p < 0.01), a history of substance abuse (eight of 59 users [14%] versus 18 of 941 nonusers [2%]; OR, 8.04; p < 0.001), insurance type (Medicaid only, 28 of 59 [48%] users versus 56 of 941 [6%] nonusers; OR, 20.45; p < 0.01), and preoperative narcotic use (eight of 59 users [14%] versus 17 of 941 nonusers [2%]; OR, 2.4; p < 0.001). We did not find differences with regard to alcohol use, amount of alcohol consumption, or insurance types other than Medicaid. Conclusions: These results suggest the legalization of marijuana has led to either more users or more patients who are willing to report its use given the lack of legal ramifications. Despite these findings, the evidence to date precludes the use of marijuana postoperatively in patients undergoing total joint arthroplasty. Further investigation, ideally in a prospective randomized manner, should focus on opioid consumption, nausea, sleep patterns, and outcomes in patients using marijuana who are undergoing total joint arthroplasty before recommendations can be made for its use. Level of Evidence: Level III, therapeutic study.

6 December 2017 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
DMDavid Clinton McNabb
David Clinton McNabb
JJJason M. Jennings
Jason M. Jennings
DLDaniel L. Levy
Daniel L. Levy
TMTodd M. Miner
Todd M. Miner
CYCharlie C. Yang
Charlie C. Yang
RKRaymond H. Kim
Raymond H. Kim
Background: The fluoroscopically assisted direct anterior approach for total hip arthroplasty has gained interest in recent years. One of the perceived advantages is the use of fluoroscopy to aid in the positioning of implants. The purpose of this study was to measure the radiation entrance surface dose to anatomically important areas of both patients and surgeons during direct anterior approach total hip arthroplasty. Methods: Radiation dosimetry badges were placed at the sternal notch and pubic symphysis of 50 patients undergoing direct anterior approach total hip arthroplasty. Badges were also placed on the surgeons outside of their lead aprons at the level of the thyroid. Three fellowship-trained arthroplasty surgeons were involved in the study. Radiation exposure of each badge was measured after each case (surgeon and patient). The cumulative dose was also calculated for the surgeons. To limit surgeon bias during the study, 50 consecutive direct anterior approach total hip arthroplasties that occurred prior to this study were analyzed for total fluoroscopic dose and time and served as a control group. Results: Forty-five subjects met study criteria. In the study group, 1 patient had a detectable thyroid exposure equal to 1 mrem. Seven patients had a detectable radiation entrance surface dose at the pubic symphysis (range, 1 to 7 mrem). No radiation entrance surface dose was detectable in the remaining 44 patients at the sternal notch and 38 patients at the pubic symphysis. Surgeons in the study did not experience a detectable radiation entrance surface dose. The mean fluoroscopic time was 13.72 seconds (range, 6.7 to 28.7 seconds). The mean patient radiation exposure was 178 mrem (range, 54 to 526 mrem). Conclusions: This study demonstrates that during direct anterior approach total hip arthroplasty, the mean patient entrance surface dose at the pubic symphysis and the sternal notch is not detectable in most patients. The mean patient exposure in this study during direct anterior approach total hip arthroplasty was 178 mrem, which is less than a single pelvic radiograph (600 mrem). No surgeon in our study demonstrated a detectable radiation entrance surface dose. Our data suggest that direct anterior approach total hip arthroplasty typically results in a negligible or very low dose of absorbed radiation exposure to the patient and the surgeon. Clinical Relevance: We believe this study to have clinical relevance because both patients and surgeons have evidence that utilization of fluoroscopy during direct anterior total hip replacement places both parties at a relatively low radiation exposure risk.

1 April 2020 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
LKLindsay T. Kleeman-Forsthuber
Lindsay T. Kleeman-Forsthuber
DDDouglas A. Dennis
Douglas A. Dennis
JJJason M. Jennings
Jason M. Jennings
Cannabis has gained widespread public advocacy since its legalization in several states with recent evidence suggesting that its self-reported use has increased in patients undergoing a primary total joint arthroplasty. The endocannabinoid system has been proposed to play a role in decreasing the inflammatory cascade and enhancing pain management. For these reasons, interest has emerged in the orthopaedic community as a potential treatment or adjunct to treatment in many musculoskeletal conditions. However, the evidence to date is scant and precludes recommendations for its widespread use. Given the current paucity of evidence in the orthopaedic cohort, future research is warranted in this area to determine the efficacy and safety before endorsements can be made by orthopaedic surgeons.

24 April 2019 in JBJS Essential Surgical Techniques
Verified
Journal Article
Closed access
MAMarc R. Angerame
Marc R. Angerame
JJJason M. Jennings
Jason M. Jennings
DHDavid C. Holst
David C. Holst
DDDouglas A. Dennis
Douglas A. Dennis
Background: Revision total knee arthroplasty is a costly operation associated with many challenges including bone loss in the distal end of the femur and proximal end of the tibia 1,2 . Reconstruction of bone defects remains a difficult problem that may require more extensive reconstruction techniques to restore mechanical stability and ensure long-term fixation. Use of porous-coated metaphyseal sleeves is a modern technique to address bone deficiency in revision total knee arthroplasty 3,4 . Midterm reports have shown excellent survivorship and osseointegration 5–7 . Description: The use of a porous-coated metaphyseal sleeve begins with intramedullary canal reaming to determine the diameter of the diaphyseal-engaging stem. Bone loss is assessed followed by broaching of the tibial and/or femoral metaphyses. Broaching continues until axial and rotational stability are achieved. The sleeve typically occupies most, if not all, of the proximal tibial and distal femoral cavitary osseous defects often encountered during revision total knee arthroplasty. However, a sleeve does not address all distal and posterior femoral condylar bone loss, for which augments are often required. Alternatives: Previously described methods to address various bone deficiencies include use of morselized or structural bone-grafting, reinforcing screws within cement, metal augments, and metaphyseal cone fixation 8–17 . Rationale: Structural allografts or metal augments remain a suitable option for uncontained metaphyseal defects. Metaphyseal structural allografts may undergo stress-shielding, resorption, and late fracture. Metaphyseal sleeves offer long-term biologic fixation to host bone while creating a stable platform to receive a cemented femoral and/or tibial component 7 . This hybrid combination may provide mechanically protective properties to decrease the loads at the cement-bone interfaces and enhance loads to metaphyseal bone to ensure long-term implant fixation in the setting of substantial bone deficiencies 18–20 .

2 September 2023 in Arthroplasty
Verified
Journal Article
Open access
PDF file
NQNicole Durig Quinlan
Nicole Durig Quinlan
JJJason M. Jennings
Jason M. Jennings
Diagnosing chronic periprosthetic joint infection (PJI) requires clinical suspicion in combination with both serological and synovial fluid tests, the results of which are generally applied to validated scoring systems or consensus definitions for PJI. As no single “gold standard” test exists, the diagnosis becomes challenging, especially in the setting of negative cultures or equivocal test results. This review aims to address the workup of chronic PJI and considerations for clinical evaluation to guide treatment. Following aspiration of the joint in question, a multitude of tests has been developed in an attempt to assist with diagnosis, including cell synovial white blood cell count, gram stain, cultures, leukocyte esterase, alpha-defensin, synovial C-reactive protein, multiplex polymerase chain reaction, next-generation sequencing, and interleukins. Each test has advantages and disadvantages and should be used in conjunction with the overall clinical picture to guide further clinical evaluation and treatment in this complex patient population.